Public Company News

The Emotional Evolution of the Intelligent Era: Tuya Smart and DeepSeek Lead the Future of AI-driven Companionship

NEW YORK, March 21, 2025 /PRNewswire/ -- Tuya Smart (NYSE: TUYA, HKEX: 2391), a global AI cloud platform service provider, is redefining the role of AI in the smart home ecosystem, turning cold technology into an emotionally intelligent companion. Imagine returning home after a long day, your mi...

2025-03-21 21:49 3035

HUYA Inc. Provides Update on Share Repurchase Program

GUANGZHOU, China, March 21, 2025 /PRNewswire/ -- HUYA Inc. ("Huya" or the "Company") (NYSE: HUYA), a leading game live streaming platform inChina, today provided an update on its ongoing share repurchase program in response to investor inquiry. As previously disclosed, under this program, the Com...

2025-03-21 20:15 2322

4BY4 to Showcase AI Video Solution 'PIXELL' at NAB 2025 with 8K Association

SEOUL, South Korea, March 21, 2025 /PRNewswire/ -- 4BY4, a leading AI-driven content solution company, has announced its participation in the upcoming2025 NAB Show (National Association of Broadcasters Show)taking place from April 5 to 9 in Las Vegas, the world's largest exhibition for broadcasti...

2025-03-21 20:00 2100

Pop Culture Group Co., Ltd Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

XIAMEN, China, March 21, 2025 /PRNewswire/ -- Pop Culture Group Co., Ltd ("Pop Culture" or the "Company") (Nasdaq: CPOP), a hip-hop culture company headquartered inChina, today announced that the Company received a notification letter (the "Notification Letter") from the Listing Qualifications De...

2025-03-21 20:00 2370

Harbour BioMed Enters into Global Strategic Collaboration with AstraZeneca to Discover and Develop Next-Generation Therapeutic Antibodies

SHANGHAI, CAMBRIDGE, Mass. and ROTTERDAM, Netherlands, March 21, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics in immunology and oncology, today announced a global ...

2025-03-21 19:21 2456

51Talk Online Education Group Announces the Results for the Fourth Quarter and Full Year 2024

SINGAPORE, March 21, 2025 /PRNewswire/ -- 51Talk Online Education Group ("51Talk" or the "Company") (NYSE American: COE), a global online education platform with core expertise in English education, announced its unaudited results for the fourth quarter and full year endedDecember 31, 2024. Full...

2025-03-21 18:10 3592

China Yuchai Subsidiary Adopts Equity Incentive Plan

SINGAPORE, March 21, 2025 /PRNewswire/ -- China Yuchai International Limited (NYSE: CYD)("China Yuchai" or the "Company") one of the largest powertrain solution manufacturers through its main operating subsidiary inChina, Guangxi Yuchai Machinery Company Limited ("Yuchai"), today announced an equ...

2025-03-21 18:00 2315

Akeso's Cadonilimab Combined with Concurrent Chemoradiotherapy Demonstrates Promising Efficacy in Locally Advanced Cervical Cancer: Data Published at the 2025 SGO Annual Meeting

HONG KONG, March 20, 2025 /PRNewswire/ -- Akeso Inc. (9926.HK) presented promising phase III safety run-in results from the COMPASSION-18/AK104-305 study, at the 2025 Annual Meeting of the Society of Gynecologic Oncology (SGO). The study evaluates the global first-in-class PD-1/CTLA-4 bispecific ...

2025-03-21 11:14 2155

BUMA Completes Inaugural Sukuk Issuance, the Largest A+ Sharia-Rated Corporate Sukuk Ijarah in a Single Issuance in Indonesia[1]

* BUMA has successfully completed the issuance of its inaugural Sukuk Ijarah I BUMA 2025, with a total value ofRp2 trillion, making it the Largest A+ Sharia-rated corporate Sukuk Ijarah in a single issuance inIndonesia[2]. * The Sukuk was oversubscribed by 1.1x, reflecting strong investor dema...

2025-03-21 10:57 2110

WuXi Biologics Named to CDP Water Security "A List" for Second Consecutive Year

* Launching the Water Excellence Stewardship (WES) program to advance UN Sustainable Development Goal 6 (SDG6) * Contributing to the 2025 World Water Day campaign to ensure the availability of water and sanitation for all SHANGHAI, March 20, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2...

2025-03-21 08:30 1931

Noul Showcases AI-Powered Cervical Cancer Cell Screening Technology at NVIDIA GTC 2025

* Company Joins NVIDIA Healthcare & Life Sciences (HCLS) Ecosystem to Advance Global Diagnostic Accessibility and Seeks Partnerships with Global Healthcare Opportunities YONGIN, South Korea, March 20, 2025 /PRNewswire/ -- Noul Co., Ltd.  a Korea-based medical AI company, announced that it presen...

2025-03-21 00:00 3056

SINEXCEL Recognized as a Tier 1 Low-Voltage Power Quality Supplier

SHENZHEN, China, March 20, 2025 /PRNewswire/ -- SINEXCEL (300693.SZ), a global pioneer in power quality, energy storage and EV charging solutions, has been recognized by Wintelligence, a leading industrial research and consulting firm, as a Tier 1 Low-Voltage Power Quality Supplier inChina. This ...

2025-03-20 21:00 2014

Seegene Unveils HPV Genotyping Solution at EUROGIN 2025

-    Presented a roadmap to enhance screening reliability at the world's leading multidisciplinary HPV congress held inPortugal from March 16-19 -    Demonstrated how self-collected samples for HPV testing can bridge gaps in cervical cancer screening and advance HPV screening goals SEOUL, South K...

2025-03-20 21:00 2058

Cheche Group Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call Date

BEIJING, March 20, 2025 /PRNewswire/ -- Cheche Group Inc. (NASDAQ: CCG) ("Cheche" or the "Company"), China's leading auto insurance technology platform, today announced it will host a conference call to discuss fourth quarter and full year 2024 results on Friday,...

2025-03-20 20:00 3261

TiumBio's Partner Hansoh Pharma Expands Indications for Merigolix (HS-10518) with Initiation of ART (Assisted Reproductive Technology) Development

* Clinical Trial Approval of merigolix (TU2670, HS-10518) for the inhibition of premature LH (luteinizing hormone) surges in women undergoing COS (controlled ovarian stimulation) inChina SEONGNAM, South Korea, March 20, 2025 /PRNewswire/ -- TiumBio (KOSDAQ: 321550), a clinical-stage biopharmace...

2025-03-20 20:00 1867

Canadian Solar's e-STORAGE to Deliver 576 MWh DC of Energy Storage Systems for Strata Clean Energy's White Tank Battery Project in Arizona

KITCHENER, ON, March 20, 2025 /PRNewswire/ -- Canadian Solar Inc . (the "Company" or "Canadian Solar") (NASDAQ: CSIQ) today announced thate-STORAGE , which is part of the Company's majority-owned subsidiary CSI Solar Co., Ltd. ("CSI Solar")...

2025-03-20 19:00 1746

Zeekr Group Files Its 2024 Annual Report on Form 20-F

HANGZHOU, China, March 20, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new energy vehicle group, today announced that it filed its 2024 annual report on Form 20-F for the fiscal year endedDecember 31, 2...

2025-03-20 18:48 3076

HUYA Inc. Announces Ex-dividend Date for Recently Announced Cash Dividend

GUANGZHOU, China, March 20, 2025 /PRNewswire/ -- HUYA Inc. ("Huya" or the "Company") (NYSE: HUYA), a leading game live streaming platform inChina, today announced that the New York Stock Exchange ("NYSE") has setJuly 1, 2025 as the ex-dividend date for the Company's cash dividend to be paid in 20...

2025-03-20 18:30 3066

Yiren Digital Reports Fourth Quarter and Fiscal Year 2024 Financial Results

BEIJING, March 20, 2025 /PRNewswire/ -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or the "Company"), an AI-powered platform providing a comprehensive suite of financial and lifestyle services inChina, today announced its unaudited financial results for the quarter endedDecember 31, 2024. F...

2025-03-20 18:19 3199

Dizal's Golidocitinib in Combination with Anti-PD-1 Shows Promise in IO Resistant Non-Small Cell Lung Cancer

* Golidocitinib is a JAK1 only inhibitor approved for the treatment of relapsed or refractory PTCL * The combination of golidocitinib and PD-1 antibody showed synergistic anti-tumor effects in anti-PD-1-resistant NSCLC SHANGHAI, March 20, 2025 /PRNewswire/ -- Dizal (SSE: 688192), a biopharmac...

2025-03-20 18:00 1810
1 ... 103104105106107108109 ... 777

Week's Top Stories